This directory combines historical reference rows with separately labelled national sources. Read the source title, observation date, printed units and conditions on each entry. National source observations do not establish all measures applicable to a shipment.

Pakistan Customs Tariff for HS Code 293399

Heterocyclic compounds; n.e.c. in headings no. 2933

See Pakistan national PCT codes and FY 2026–27 base duties

Pakistan Fifth Schedule — conditional concession references

1,176 official source entries are searchable. Checked 2026-09-22.

Exact printed code-cell references from the Fifth Schedule updated 30 June 2026, with complete numbered-entry descriptions, governing Part text and continued conditions. Blank or merged cells remain unassigned; no importer eligibility, preference or total duty is selected. Product-only, heading-only and omitted entries are not automatically assigned national codes. Base CD, ACD, RD and other taxes remain separate. Parts and tables may contain expired, quota-limited or otherwise restricted provisions: the original conditions control.

Original source definitions and general notes

Read the complete Fifth Schedule, including product-only provisions and Part VII miscellaneous rules. Exact code indexing is not a determination that other provisions do not apply.

The Second Schedule [(See section 3(14)] In the Customs Act, 1969 (IV of 1969), FOR THE Fifth Schedule, the following shall be substituted, namely:- “THE FIFTH SCHEDULE [see section 18(1A)] Part-I Import of Plant, Machinery, Equipment and Apparatus, including Capital Goods for various industries/sectors Note: - For the purposes of this Part, the following conditions shall apply, besides the conditions as specified in column (5) of the Table below: - (i) the imported goods as are not listed in the locally manufactured items, notified through a Customs General Order issued by the Federal Board of Revenue (FBR) from time to time or, as the case may be, certified as such by the Engineering Development Board: Provided that the condition of “local manufacturing” shall not be applicable on import of machinery, equipment and other capital goods imported as plant for setting up of a new power unit of 25 MW and above duly certified by Ministry of Water and Power in respect of those power projects which are on IPP mode meant for supply of electricity to national grid; Provided further that condition of local manufacturing shall not be applicable for a period of three years, commencing on 1st July, 2018 and ending on 30th June, 2021, against Sr.No.12 of Table under Part-I of Fifth Schedule to the Customs Act, 1969, on import of machinery, equipment and other capital goods imported for new private transmission lines projects under the valid contract (s) or letter (s) of credit and the total C&F value of such imports for the project is US $ 50 million or above duly certified by the Ministry of Energy (Power Division); Provided further that condition of local manufacturing shall not be applicable against Sr. No.38 of the Table, on import of plant, machinery and equipment if imported by registered pharmaceutical manufacturers for their own use subject to NOC from Ministry of Health. Provided further that condition of local manufacturing shall not be applicable against Sr. No.15A and 29 of the Table. (ii) except for S. Nos. 1(H), 14, 20,21 and 22 of the Table, the Chief Executive, or the person next in hierarchy duly authorized by the Chief Executive or Head of the importing company shall certify in the prescribed manner and format as per Annex-A that the imported items are the company’s bona fide requirement. He shall furnish all relevant information online to Pakistan Customs Computerized System against a specific user ID and password obtained under section 155D of the Customs Act, 1969 IV of 1969). In already computerized Collectorates or Customs stations where the Pakistan Customs Computerized System is not operational, the Director Reforms and Automation or any other person authorized by the Collector in this behalf shall enter the requisite information in the Pakistan Customs Computerized System on daily basis, whereas entry of the data obtained from the customs stations which have not yet been computerized shall be made on weekly basis; (iii) in case of partial shipments of machinery and equipment for setting up a plant, the importer shall, at the time of arrival of first partial shipment, furnish complete details of the machinery, equipment and components required for the complete plant, duly supported by the contract, lay out plan and drawings; (iv) For "Respective Headings" entries in column (3) of the Table against which more than one rate of customs duty has been mentioned in column (4), the rate of 0%, 3% or 11% shall be applicable only for such goods which are chargeable to 0%, 3% or 11% duty respectively under the First Schedule to the Customs Act, 1969. In all such type of entries, a maximum concessionary rate (i.e. 5%, 10% or 15%) has also been mentioned in column (4) of each entry which shall be applicable on the goods which are subject to any of the all remaining higher duty slab rates under the First Schedule to the Customs Act, 1969. Explanation I.– In entries where customs duty rates 0%, 3% and 5% have been mentioned in column (4), the rate 0% or 3% shall be applicable only for such goods which are chargeable to 0% or 3% duty respectively under First Schedule to the Customs Act, 1969. Whereas for all higher slabs (11%, 16%, 20% and above) concessionary rate of 5% shall be applicable. 2 Explanation II. – In entries where customs duty rates 3%, 5% have been mentioned in column (4), the rate 3% shall be applicable only for such goods which are chargeable to 3% duty under First Schedule to the Customs Act, 1969. Whereas for all higher slabs (11%, 16%, 20% and above) concessionary rate of 5% shall be applicable. Explanation III. – In entries where customs duty rates 0%, 3%, 10% have been mentioned in column (4), the rate 0% or 3% shall be applicable only for such goods which are chargeable to 0% or 3% duty respectively under First Schedule to the Customs Act, 1969. Whereas for all higher slabs (11%, 16%, 20% and above) concessionary rate of 10% shall be applicable. Explanation IV. – In entries where customs duty rates 0%, 3%, 11%, 15% have been mentioned in column (4), the rate 0%, 3% or 11% shall be applicable only for such goods which are chargeable to 0%, 3% or 11% duty respectively under First Schedule to the Customs Act, 1969. Whereas for all higher slabs (16%, 20% and above) concessionary rate of 15% shall be applicable.; and (v) Goods imported temporarily for projects under serial numbers 9, 10, 11 and 12, if not re-exported on the conclusion of the project, may be allowed retention or transfer after conclusion of the project, from one company or project to another entitled company or project, with prior approval of the Board, against payment of 0.25% surcharge on C&F value of the goods for each year of retention, besides payment of duties and taxes, chargeable, if any. Explanation. - Capital Goods mean any plant, machinery, equipment, spares and accessories, classified in Chapters 84, 85 or any other chapter of the Pakistan Customs Tariff, required for- (a) the manufacture or production of any goods, and includes refractory bricks and materials required for setting up a furnace, catalysts, machine tools, packaging machinery and equipment, refrigeration equipment, power generating sets and equipment, instruments for testing, research and development, quality control, pollution control and the like; and (b) use in mining, agriculture, fisheries, animal husbandry, floriculture, horticulture, livestock, cool chain, dairy, poultry industry, IT sector, storage, communication and infrastructure development of SEZs by Zone Developer. TABLE

Table E (Diagnostic Kits/Equipment) [Omitted] Part-III Raw Materials/Inputs for Poultry and Textile Sector; Other Goods The imports under this part shall be subject to following conditions, besides the conditions specified in the Table given below namely: - (i) the designated/authorized person of the following Ministries, or as the case may be, companies shall furnish all relevant information as detailed in the table below on line to the Customs Computerized System, accessed through the unique users identifier obtained under section 155D of the Customs Act, 1969, along with the password thereof, namely: - (a) Ministry of Industries, Production and Special Initiatives, in case of imported goods specified against serial numbers 24of Table; (b) M/s Lotte Chemical Pakistan Ltd, in case of imported goods specified against serial number 35 of Table; (c) Ministry of National Food Security and Research, in case of goods, specified against serial number 24 and 29 of Table; (ii) Omitted. (iii) in already computerized Collectorates and Custom-stations where the Customs Computerized System is not yet operational, the Director Reforms and Automation or any other authorized officer shall feed the requisite information about clearance/release of goods under this notification in the Customs Computerized System on daily basis, and the data obtained from the Custom-stations, which have not yet been computerized, on weekly basis. Table

Part-IV Imports of Machinery and Equipment for Textile Sector TABLE

Explanation: - For the purpose of this Part the expression “excluding those manufactured locally” means the goods which are not included in the list of locally manufactured goods specified in General Order issued by the Federal Board of Revenue or as the case may be, certified as such by the Engineering Development Board. Part-V (Omitted vide Finance Act, 2023) Part-V(A) Import of Electric Vehicles (EV) CBU & their Parts Under Electric Vehicle Policy 2020 TABLE-I [For 2-3 Wheelers, 4-Wheelers & Heavy Commercial Vehicles (CBUs)]

Explanation: - For the purpose of this Part the expression “excluding those manufactured locally” means the goods which are not included in the list of locally manufactured goods specified in General Order issued by the Federal Board of Revenue or as the case may be, certified as such by the Engineering Development Board. Part-V (Omitted vide Finance Act, 2023) Part-V(A) Import of Electric Vehicles (EV) CBU & their Parts Under Electric Vehicle Policy 2020 TABLE-I [For 2-3 Wheelers, 4-Wheelers & Heavy Commercial Vehicles (CBUs)] TABLE-II [For CKD & EV Specific Parts]

Explanation: - For the purpose of this Part the expression “excluding those manufactured locally” means the goods which are not included in the list of locally manufactured goods specified in General Order issued by the Federal Board of Revenue or as the case may be, certified as such by the Engineering Development Board. Part-V (Omitted vide Finance Act, 2023) Part-V(A) Import of Electric Vehicles (EV) CBU & their Parts Under Electric Vehicle Policy 2020 TABLE-I [For 2-3 Wheelers, 4-Wheelers & Heavy Commercial Vehicles (CBUs)] TABLE-III [Miscellaneous]

Part-V(B) Import of Hybrid Electric Vehicles (CBUs) Under Auto Industry Development and Export Policy (AIDEP) 2021-26 TABLE-I

Part-V(B) Import of Hybrid Electric Vehicles (CBUs) Under Auto Industry Development and Export Policy (AIDEP) 2021-26 TABLE-I TABLE-II Import of Parts for Hybrid Vehicles Under Auto Industry Development and Export Policy (AIDEP) 2021-26

Part V(C) Import of Agricultural Tractors TABLE

Part-VI Imports of Aviation Related Goods i.e. Aircrafts and Parts etc. by Airline Companies/Industry under National Aviation Policy 2023 Note: - For the purposes of this Part, the following conditions shall apply besides the conditions as specified in column (5) of the Table below: - (i) The exemption shall be admissible to Maintenance, Repair & Overhaul Companies (MROs) and Aircraft Maintenance Organizations (AMOs) duly authorized by the Defence Division, and the Airline Companies having valid registration and license from the Pakistan Civil Aviation Authority under the Pakistan Civil Aviation Act, 2023 duly shared with the Customs Computerized System or Pakistan Single Window to the effect that the intending importer is operating in the country or intends to operate in the country in the airline sector; 55 (ia) The list of imported items is duly approved by the Pakistan Airports Authority, Defence Division, Government of Pakistan for every consignment imported by MRO or AMO in line with Policy Framework approved by the Government of Pakistan; (ii) The Chief Executive, or the person next in hierarchy duly authorized by the Chief Executive or Head of the importing Company shall certify that the imported goods/items are the company's bonafide requirement and shall be used for the purpose as defined/notified by the Defence Division, Government of Pakistan under the Aviation Policy. The importer shall declare all relevant information to the Customs while claiming exemption regarding genuineness of the claim through Customs computerized system or Pakistan single window; and (iii) In case of deviation from the above stipulations, the Collector of Customs shall initiate proceedings for recovery of duty and taxes under the relevant laws. TABLE

Part-VII Miscellaneous [Omitted] Part-VIII Imports of specific Goods allowed at Joint Border Sustenance Markets In order to ensure smooth functioning and operationalization of Border Markets in specific border areas, the imports under this part shall be subject to following conditions, namely. - (i) Border markets will be functional for two days each week and total allowance per day for the visitor will be $100. (ii) The Customs Value of imported goods will be displayed for ascertaining the admissible quantities of imported goods. (iii) The visitor will purchase goods from any category up to US $50 on concessional rate of leviable duty/taxes as mentioned in column (4) of the Table. (iv) In case, a visitor chooses to purchase goods of value more than $50 from a specific category, it will be considered as commercial quantity being liable to duty/taxes on statutory rates. (v) The Customs staff posted at the border market will make an entry via electronic system for the goods purchased by the visitor on the prescribed format as notified by the Board. (vi) A system generated receipt will be issued to the visitor bearing his Name & CNIC No. by the Custom Officer in respect of goods purchased along with payable Customs Duty. Table

Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)

Official schedule and source documentation

Official entries matching 293399

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 2

Albendazole - Human Grade

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 23. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 7

Amiloride HCL

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 23. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 17

Atorvastatin

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 23. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 18

Atorvastatin Calcium

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 23. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 32

BUPIVACAINE HYDROCHLORIDE

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 24. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 36

Candesartan Cilextle

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 24. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 37

Captopril

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 24. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 38

Carbamazepine

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 24. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 43

CARVEDILOL

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 24. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 62

Clamipramine Hcl Ep

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 24. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 65

Clemastine Hydrogen Fumarate

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 24. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 79

Dextro Methophen HBR

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 25. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 97

Enalapril Maleate Usp 23

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 25. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 109

Etoricoxib

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 26. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 110

Euflavine Bp (Acriflavine)

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 26. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 113

Favipiravir

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 26. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 115

Fenpiverinium Bromide

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 26. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 125

Fluconazole

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 26. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 126

Flumequine Base

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 26. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 138

Gemifloxacin Mesylate

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 26. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 153

Imipramine Hydrochlor/Ds 01

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 27. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 161

Ketorolac Tromethamine

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 27. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 167

Letrozole

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 27. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 172

Linaclotide and its derivatives

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 27. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 177

Lisinopril and its derivatives

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 27. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 190

Metronidazole Benzoate

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 27. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 201

NICORANDIL

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 28. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 209

Olaquindox

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 28. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 214

Oxfendozale

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 28. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 223

Pheneramine Maleate

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 28. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 224

Pindolol Base/Ds Pur

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 28. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 240

Procyclidine Hcl

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 29. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 245

Ramipril

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 29. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 258

Sacubitril + Valsartan

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 29. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 259

Saxagliptin HCl

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 29. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 260

Silodosin

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 29. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 272

Telmisartan

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 29. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 289

Trandolapril

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 30. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 293

Triclabendazole

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 30. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 297

Valsartan

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 30. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 302

Vonoprazone Fumarate

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 30. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 308

Zoledronic Acid Monohydrate

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 30. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 309

Zolpidem Hemitartrate

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 30. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 397

Lenalidomide Hemihydrate

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 33. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 398

Lenalidomide Anhydrous

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 33. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 399

Lenvatinib

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 33. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 404

Osimeritinib

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 33. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 427

2,8-Diazabicyclo [4,3,0] nonane (Moxifloxacin Side Chain)

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 33. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 447

3,6-Dichloropyrazine-2-carbonitrile

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 34. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table A — entry 449

Valsartan methyl ester

Printed conditional customs duty (%) — eligibility not established
0
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 34. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code

2933.9990

Fifth Schedule — Part II — pharmaceutical substances and related goods › Table B — entry 41

1-H-tetrazole-1-acetic acid[TAA](Pharmaceutical grade)

Printed conditional customs duty (%) — eligibility not established
5%
Source notes and context notes
  • Exact code mention in a conditional concession, not a replacement for the national base tariff or a determination that the importer qualifies. All original Part II conditions below apply. ACD, RD, sales tax and other measures require separate review.
  • Entry continues across PDF pages 36. Read the complete description and source document.
  • Part-II Import of Active Pharmaceutical Ingredients, Excipients/Chemicals, Drugs, Packing Material/ Raw Materials for Packing and Diagnostic Kits and Equipment, Components and other Goods The Imports under this part shall be subject to following conditions, namely. - (i). The active pharmaceutical ingredients, Excipients /chemicals, packing material and raw material for packing shall be imported only for in-house use in the manufacture of specified pharmaceutical substances, as approved by the Drug Regulatory Agency of Pakistan. (ii). The requirement for active pharmaceutical ingredients and Excipients/chemicals, drugs as specified in Table A, B & C, shall be determined by the Drug Regulatory Agency of Pakistan; (iii). The requirement for packing materials/raw materials for packing, as specified in Table-D, shall be determined by Input Output Coefficient Organization; (iv). The designated/authorized representative person of Drug Regulatory Agency of Pakistan shall furnish all relevant information, as set out in this part, online to the Customs computerized system, accessed through the unique user identifier obtained under section 155 d of the Customs Act 1969, along with the password thereof. (v). For "Respective Headings" entries in column (3) of the Table against which two rates of customs duty 3% and 5% have been mentioned in Column (4), the rate of 3% shall be applicable only for such goods which are chargeable to 3% duty under the First Schedule to the Customs Act 1969. Table A Active Pharmaceutical Ingredients (API)
Official source for this code
WITS 2023 historical MFN average

Reported average: 5.5%.

Source year: 2023. Classification: HS 2022 (H6). Checked 2026-09-14.

National lines included: 2 of 2. Excluded from the average: 0.

Reported ad-valorem range: 0%–11%.

Reported historical ad-valorem MFN simple average for 2023, not a national tariff schedule. No preferential rates, additional duties, VAT, excise or import permissions are determined.

Not a current 2026 national duty. The HS6 average does not determine the duty of a particular national subdivision, origin or shipment.

WITS observation for this code and year

UN Comtrade H6 descriptions (HS 2022)

WITS API definitions: reported averages and excluded national lines

Direct HS code answer for Pakistan

Pakistan HS Code 293399: 5.50% (2023 MFN average)

The source reports an indicative HS6 MFN average of 5.50% (2023 MFN average) for Heterocyclic compounds; n.e.c. in headings no. 2933.Source status: not assessed. Verify the exact national tariff line, origin treatment, taxes, restrictions, and current customs guidance before using this information in a declaration.

Customs tariff summary

Country
Pakistan
HS / tariff code
293399
Description
Heterocyclic compounds; n.e.c. in headings no. 2933
Chapter
29 —
Heading
2933
Subheading
293399
Indicative MFN HS6 average
5.50% (2023 MFN average)
VAT / tax
Check local VAT and excise rules for the import destination.
Unit / basis
Not listed in this tariff line
Source / vintage
WITS / UNCTAD TRAINS — 2023 MFN HS6 reference

Historical MFN average

5.50% (2023 MFN average)

Import permission

not assessed

Pakistan national customs-duty references — FY 2026–27

These eight-digit PCT codes share the prefix 293399. The FBR schedule reports the base customs duty (CD), separately from the historical WITS average above. Checked 2026-09-14; no line-level effective date is inferred.

CD is not the total import charge. Additional customs duty, regulatory duty, taxes, trade remedies, origin treatment and conditional concessions require separate checks.

Description excerpts are provided for navigation. Read the linked PDF page, headings and continuation text for the full product scope. A listed duty does not establish import permission.

Additional duties and conditional concessions — rules from July 2026

Reviewed 2026-09-15. SRO 1063/2026 (additional customs duty, ACD) and SRO 1064/2026 (regulatory duty, RD) take effect on 2026-07-01. The references below are separate from base CD. They do not calculate the amount due for your shipment.

Sales tax and advance income tax references

Checked 2026-09-22. These taxes require separate review of exemptions, schedules, importer status and valuation. A code mention is navigation only; no rate or eligibility is assigned.

Check ACD exemptions and import schemes first

Paragraph 3 of SRO 1063 lists exemptions for manufacturing or production machinery in chapters 84–85, chapter 99 imports, qualifying Fifth Schedule imports, baggage, temporary imports and specified schemes. Merely belonging to a chapter or finding a code in the Fifth Schedule does not establish eligibility.

The Fifth Schedule ACD exemption excludes Part I entries 30, 33 and 35, and Part III entries 102, 111, 116 (except xvi), 117 and 118. Imports under SROs 655/2006 and 656/2006 have a separate 2% rule; check the exemptions and vehicle provisions before applying it.

Vehicles require their assembly condition and engine capacity: paragraph 1(ii)(b)(ii) specifies 2% for certain CKD vehicles; paragraph 3(x) exempts specified CKD vehicles up to 1,000cc and CBU vehicles up to 850cc. Paragraph 3(xi) lists three exact PCT exemptions. Check the complete scheme conditions. ACD uses the customs value determined under sections 25 or 25A.

ACD exceptions and valuation — SRO 1063, page 2

Regulatory duty needs product and import details

The 687 numbered SRO 1064 table entries have been reviewed. Matched references below retain heading rules, product exclusions and value bands. A code may have several treatments. Unmatched printed codes require classification review; absence of a matched rule is not a confirmed zero. Its paragraphs 2–5 also cover conditional exemptions, home-appliance CKD/SKD kits, certain goods imported from Afghanistan and valuation of protected vehicles.

The Fifth Schedule RD exemption has different exceptions from ACD: Part I entries 22 and 23(v), and Part III entries 99, 100, 102, 116(iv), 116(xvi) and 146. Check each levy separately.

RD exemptions also cover the qualifying regimes in paragraph 2: SRO 678/2004, chapter 99, temporary imports under SRO 492/2009, specified seamless-pipe manufacturing inputs, rubber apron and cots, eligible new-entrant vehicle imports and local auto-parts inputs. The complete conditions remain controlling.

Product-only entry 686: 20%. Plums (allocha); no PCT code is specified in this entry. The source says “respective headings”; no national code has been assigned automatically. Read entry 686

Product-only entry 687: PKR 2,400 per minute. Cinematographic film; no PCT code is specified in this entry. The source says “respective headings”; no national code has been assigned automatically. Read entry 687

Concessions depend on eligibility

Fifth Schedule entries can require a specified use, importer, certification, quota, date or other conditions. Read the Part notes, table description and conditions, including text continued on later pages. A code occurrence is a place to review, not an exemption decision. The page links are a partial navigation index; no match does not mean no concession or no RD.

Complete Fifth Schedule and conditions

29339910

- - - Ingredients for pesticides

Base CD in the schedule: 0%

Full product scope and CD — PDF page 75

Additional customs duty reference: No ACD amount assigned from the tariff slab alone. Import schemes and the exceptions must still be checked; this is not a confirmed zero.

SRO 1063 — clause 1(i)(c) and 3, page 1

No RD amount assigned to this national code. This is not a confirmed zero; check the full table and classification.

Sales tax and advance income tax — source references

Exact code mentions only, checked 2026-09-22. They do not establish applicability, exemption or a tax rate. Heading-based and product-only rules may also apply; consult the complete documents.

Sales Tax Act 1990 — consolidated through 30 June 2026: PDF page 171

Income Tax Ordinance 2001 — official consolidated reference: No exact code match — review the full document

Find regulatory duty and concession references for 29339910

Code mentions guide you to the documents. Review the full description, heading rules, exceptions and Part notes; no eligibility or total duty is inferred.

Regulatory duty: Check the full table, including heading rules

Conditional concessions: Check the full Fifth Schedule

29339990

- - - Other

Base CD in the schedule: 10%

Full product scope and CD — PDF page 75

Additional customs duty reference: No ACD amount assigned from the tariff slab alone. Import schemes and the exceptions must still be checked; this is not a confirmed zero.

SRO 1063 — clause 1(i)(c) and 3, page 1

No RD amount assigned to this national code. This is not a confirmed zero; check the full table and classification.

Sales tax and advance income tax — source references

Exact code mentions only, checked 2026-09-22. They do not establish applicability, exemption or a tax rate. Heading-based and product-only rules may also apply; consult the complete documents.

Sales Tax Act 1990 — consolidated through 30 June 2026: No exact code match — review the full document

Income Tax Ordinance 2001 — official consolidated reference: No exact code match — review the full document

Find regulatory duty and concession references for 29339990

Code mentions guide you to the documents. Review the full description, heading rules, exceptions and Part notes; no eligibility or total duty is inferred.

Regulatory duty: Check the full table, including heading rules

Conditional concessions: Fifth Schedule page 23Fifth Schedule page 24Fifth Schedule page 25Fifth Schedule page 26Fifth Schedule page 27Fifth Schedule page 28Fifth Schedule page 29Fifth Schedule page 30Fifth Schedule page 33Fifth Schedule page 34Fifth Schedule page 36

Import planning

Need a landed cost report for this HS code?

Request a one-page research summary with source checks, landed-cost inputs, and points to verify for HS code 293399 in Pakistan.

Get report

Details

HS Code
293399
Chapter
29 —
Heading
2933
Subheading
293399

Compare HS code 293399 across GCC countries

Each destination shows its own source label. Oman uses its national schedule; Qatar and UAE entries may cite their separately published references and unresolved exceptions. Other entries retain the historical GCC reference. National codes, duty notes, restrictions and tax treatment can differ; verify with the destination customs authority.

Related HS Codes (Heading 2933)

HS CodeDescriptionDuty
293311Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, phenazone (antipyrin) and its derivatives0.00% (2023 MFN average)WITS 2023 historical MFN average
293319Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivatives0.00% (2023 MFN average)WITS 2023 historical MFN average
293321Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused imidazole ring (whether or not hydrogenated) in the structure, hydantoin and its derivatives0.00% (2023 MFN average)WITS 2023 historical MFN average
293329Heterocyclic compounds; with nitrogen hetero-atom(s) only, containing an unfused imidazole ring (whether or not hydrogenated) in the structure, other than hydantoin and its derivatives0.00% (2023 MFN average)WITS 2023 historical MFN average
293331Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, pyridine and its salts0.00% (2023 MFN average)WITS 2023 historical MFN average
293332Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, piperidine and its salts0.00% (2023 MFN average)WITS 2023 historical MFN average
293333Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), carfentanil (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN)0.00% (2023 MFN average)WITS 2023 historical MFN average
293334Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other fentanyls and their derivatives11.00% (2023 MFN average)WITS 2023 historical MFN average
293335Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, 3-quinuclidinol0.00% (2023 MFN average)WITS 2023 historical MFN average
293336Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, 4-anilino-N-phenethylpiperidine (ANPP)11.00% (2023 MFN average)WITS 2023 historical MFN average
293337Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, N-phenethyl-4-piperdone (NPP)11.00% (2023 MFN average)WITS 2023 historical MFN average
293339Heterocyclic compounds; containing an unfused pyridine ring (whether or not hydrogenated) in the structure, n.e.c. in 2933.36.20% (2023 MFN average)WITS 2023 historical MFN average
293341Heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, levorphanol (INN) and its salts0.00% (2023 MFN average)WITS 2023 historical MFN average
293349Heterocyclic compounds; containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) in the structure, not further fused, other than levorphanol (INN) and its salts0.60% (2023 MFN average)WITS 2023 historical MFN average
293352Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, malonylurea (barbituric acid) and its salts0.00% (2023 MFN average)WITS 2023 historical MFN average
293353Allobarbital (INN), amobarbital (INN), barbital (INN), butalbital (INN), butobarbital, cyclobarbital (INN), methylphenobarbital (INN), pentobarbital (INN), phenobarbital (INN), secbutabarbital (INN), secobarbital (INN) and vinylbital (INN); salts thereof0.00% (2023 MFN average)WITS 2023 historical MFN average
293354Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, other derivatives of malonylurea (barbituric acid) and salts thereof, n.e.c. in 2933.530.00% (2023 MFN average)WITS 2023 historical MFN average
293355Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure; loprazolam (INN), mecloqualone (INN), methaqualone (INN), and zipeprol (INN); salts thereof0.00% (2023 MFN average)WITS 2023 historical MFN average
293359Heterocyclic compounds; containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, (other than malonylurea and its derivatives, loprazolam, mecloqualone, methaqualone, zipeprol, and salts thereof) n.e.c. in 2933.58.50% (2023 MFN average)WITS 2023 historical MFN average
293361Heterocyclic compounds; containing an unfused triazine ring (whether or not hydrogenated) in the structure, melamine0.00% (2023 MFN average)WITS 2023 historical MFN average

Data source: WITS/UNCTAD TRAINS (MFN 2022). Values are indicative HS6 MFN averages, not shipment-specific applied rates. Import permission and restrictions are not assessed. Historical reference rates exclude VAT, excise and other national measures. Separate national entries preserve the columns printed by their source; these are not a complete shipment assessment. Full disclaimer.